Zai Lab Ltd

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net loss ($37.5m) ($50.4m) ($139.1m) ($195.1m)
Net Income (Loss) Attributable to Parent ($37.5m)
($50.4m) -34.31%
($139.1m) -176.03%
($195.1m) -40.26%
($268.9m) -37.85%
($704.5m) -161.98%
($443.3m) +37.08%
($334.6m) +24.51%
($257.1m) +23.17%
($175.5m) +31.73%
Depreciation, Depletion and Amortization $3.8m $4.6m $6.5m $8.2m $9.0m $11.9m $15.0m $15.9m
Depreciation $198k $546k $1.6m $3.4m $1.6m $6.0m $7.7m $8.4m $8.6m $9.1m $15.9m
Amortization of Debt Issuance Costs $700k $194k
Amortization of Intangible Assets $781 $2k $15k $305k $307k $493k $500k $700k $3.2m $5.9m
Depreciation and amortization expenses $548k $1.6m $3.8m $15.9m
Amortization of deferred income ($78k) ($312k) ($312k)
Share-based Payment Arrangement, Noncash Expense $4.9m $9.9m $12.2m $20.3m $24.8m $40.7m $61.3m $79.6m $70.7m $65.6m $58.3m
Payment, Tax Withholding, Share-based Payment Arrangement $8.8m $0 $8.2m
Share-based Payment Arrangement, Expense $61.3m $79.6m $70.7m $65.6m $58.3m
Share-based compensation $4.9m $9.9m $12.2m $20.3m $58.3m
Income (Loss) from Equity Method Investments ($250k) ($587k) ($1.1m) ($1.1m) ($221k) $0 $0
Other Nonoperating Income (Expense) $938k $29.1m ($5.5m) $3.1m $7.0m $5.3m $3.5m
Share of loss from equity method investment $35.1m $250k $587k $752k
Purchase of equity method investment ($1.9m) ($2.1m)
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $90k $3.7m $1.4m $42.3m ($4.3m) $20.0m $27.0m $18.9m $26.3m
Accounts receivable ($90k) ($3.7m) $26.3m
Increase (Decrease) in Inventories $4k $6.0m $7.2m $7.2m $15.4m $14.9m ($3.9m) $47.0m ($46.8m)
Inventory Write-down $0 $0 $29k $1.4m $477k $973k $815k $12.3m
Inventories ($4k) ($6.0m) ($46.8m)
Increase (Decrease) in Accounts Payable ($930k) $8.4m $28.5m ($14.8m) $40.0m $63.5m ($53.8m) $36.8m ($2.2m) $19.9m $16.3m
Prepayments and other current assets ($75k) ($811k) ($4.8m) ($1.1m)
Other current liabilities $1.9m $7.1m $9.1m ($7k)
Net Cash Provided by (Used in) Operating Activities ($32.2m)
($32.4m) -0.65%
($97.5m) -201.35%
($191.0m) -95.83%
($216.1m) -13.11%
($549.2m) -154.21%
($367.6m) +33.06%
($198.2m) +46.09%
($214.9m) -8.42%
($150.8m) +29.82%
($133.4m) +11.54%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $2.2m $9.1m $10.0m $6.0m $10.1m $18.3m $24.6m $7.2m $5.7m $8.1m ($29.1m)
Gain (Loss) on Disposition of Property Plant Equipment ($13k) ($704) ($15k) $21k ($29k) ($560k) ($159k) ($453k) ($542k) ($45.6m)
Purchases of short-term investments ($200.3m) ($277.6m)
Net Cash Provided by (Used in) Investing Activities ($2.7m) ($10.4m) ($212.6m) ($14.9m) ($554.8m) $250.0m $420.0m ($10.8m) ($375.2m) $307.9m ($39.0m)
Cash flows from financing activities:
Proceed from short-term borrowings $3.6m $7.3m
Proceeds from Issuance of Common Stock $217.3m $0 $0
Net Cash Provided by (Used in) Financing Activities $106.2m
$187.9m +76.89%
$144.1m -23.27%
$219.3m +52.14%
$1.1b +416.38%
$820.2m -27.57%
($1.7m) -100.21%
($6.4m) -271.85%
$349.9m +5538.97%
$72.4m -79.32%
$44.6m -38.30%
Net increase (decrease) in cash, cash equivalents and restricted cash $145.7m ($166.7m) $13.5m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13.5m $366.4m $522.0m $44.4m ($218.0m) ($240.5m) $229.9m $705.6m
Cash, cash equivalents and restricted cash - beginning of the year $229.7m $63.0m $76.4m
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash $652k ($763k) $91k
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $66k $196k $1.1m $6.7m $7.4m $5.9m $2.4m $3.2m $13.7m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $36k $288k $189k $0 $0 $2.0m $4.9m
Additional Financial Items
Equity Securities, FV-NI, Gain (Loss) ($9.0m) $2.8m ($6.1m) ($1.9m)
Foreign Currency Transaction Gain (Loss), before Tax ($56.4m) ($14.8m) ($15.1m) $19.6m
Foreign Currency Transaction Gain (Loss), Unrealized ($56.4m) ($14.8m) ($15.1m) $19.6m
Gain (Loss) on Disposition of Intangible Assets $10.0m $0 $0
General and Administrative Expense $6.4m $12.0m
Income Tax Expense (Benefit) $0 $0 $0 $0 $0 $0 ($2.9m)
Interest Expense Nonoperating $5.2m
Investment Income, Interest $403k $527k $3.3m $8.2m $5.1m $2.2m $14.6m $39.8m $37.1m $33.0m
Operating Lease, Expense $286k $917k $1.5m
Change in fair value of warrants $1.9m ($200k)
Long term deposits ($268k) ($39k) ($250k) $180k
Value added tax recoverable ($1.4m) ($3.7m) ($3.0m) ($5.7m)
Deferred income $717k $1.6m ($18k) $1.1m
Purchase of intangible assets ($6k) ($15k) ($103k) ($1.4m)
Proceed from issuance of convertible preferred shares, net of issuance cost $106.2m $29.1m
Proceeds from exercises of stock options $66k $196k $1.1m
Proceeds from issuance of ordinary shares upon public offerings $160.4m $141.0m $216.2m
Payment of public offering costs ($2.7m) ($692k) ($854k)
Cash and cash equivalents $83.9m $229.7m $63.0m $75.9m $833.4m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.